Dawood Yusef1, Wail A Hayajneh1, Ali Bani Issa2, Rami Haddad3, Sayer Al-Azzam4, Elizabeth A Lattyak5, William J Lattyak5, Ian Gould6, Barbara R Conway7,8, Stuart Bond9, Geraldine Conlon-Bingham10, Mamoon A Aldeyab7. 1. Department of Paediatrics and Neonatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan. 2. Infection Control Division, King Abdullah University Hospital, Irbid, Jordan. 3. Information Technology Department, King Abdullah University Hospital, Irbid, Jordan. 4. Clinical Pharmacy Department, Jordan University of Science and Technology, Irbid, Jordan. 5. Scientific Computing Associates Corp., River Forest, IL, USA. 6. Medical Microbiology Department, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK. 7. Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK. 8. Institute of Skin Integrity and Infection Prevention, University of Huddersfield, Huddersfield, UK. 9. Pharmacy Department, Mid Yorkshire Hospitals NHS Trust, Wakefield, UK. 10. Pharmacy Department, Craigavon Area Hospital, Craigavon, Northern Ireland, UK.
Abstract
OBJECTIVES: To evaluate the impact of an antimicrobial stewardship programme (ASP) on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitalized patients. METHODS: The study was a retrospective, ecological assessment in a tertiary teaching hospital over 6 years (January 2014 to December 2019). The intervention involved the implementation of an ASP in February 2018, which remains in effect today. This ASP consists of several components, including education, antibiotic guidelines, antibiotic restriction policy with prior approval, audit of compliance to the restriction policy and feedback. Restricted antibiotics were imipenem/cilastatin, ertapenem, meropenem, vancomycin, teicoplanin, tigecycline, colistin, amikacin, piperacillin/tazobactam, levofloxacin and ciprofloxacin. The intervention was evaluated by time-series methods. RESULTS: Statistically significant decreases in the level of antibiotic use, after the introduction of the ASP, were observed for the following antibiotics: imipenem/cilastatin (P = 0.0008), all carbapenems (P = 0.0001), vancomycin (P = 0.0006), colistin (P = 0.0016) and third-generation cephalosporins (P = 0.0004). A statistically significant decrease in the slope, after the introduction of the ASP, for ertapenem (P = 0.0044) and ciprofloxacin (P = 0.0117) was observed. For piperacillin/tazobactam, there was a significant increasing trend (P = 0.0208) before the introduction of the ASP. However, this increased trend was halted post-introduction of the ASP (P = 0.4574). The introduction of the ASP was associated with a significant impact on reducing the levels of CRAb (P = 0.0237). CONCLUSIONS: The introduced antimicrobial stewardship interventions contributed to a reduction in the use of several broad-spectrum antibiotics, reversed the trends of increasing use of other antibiotics and were associated with a significant reduction in CRAb.
OBJECTIVES: To evaluate the impact of an antimicrobial stewardship programme (ASP) on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitalized patients. METHODS: The study was a retrospective, ecological assessment in a tertiary teaching hospital over 6 years (January 2014 to December 2019). The intervention involved the implementation of an ASP in February 2018, which remains in effect today. This ASP consists of several components, including education, antibiotic guidelines, antibiotic restriction policy with prior approval, audit of compliance to the restriction policy and feedback. Restricted antibiotics were imipenem/cilastatin, ertapenem, meropenem, vancomycin, teicoplanin, tigecycline, colistin, amikacin, piperacillin/tazobactam, levofloxacin and ciprofloxacin. The intervention was evaluated by time-series methods. RESULTS: Statistically significant decreases in the level of antibiotic use, after the introduction of the ASP, were observed for the following antibiotics: imipenem/cilastatin (P = 0.0008), all carbapenems (P = 0.0001), vancomycin (P = 0.0006), colistin (P = 0.0016) and third-generation cephalosporins (P = 0.0004). A statistically significant decrease in the slope, after the introduction of the ASP, for ertapenem (P = 0.0044) and ciprofloxacin (P = 0.0117) was observed. For piperacillin/tazobactam, there was a significant increasing trend (P = 0.0208) before the introduction of the ASP. However, this increased trend was halted post-introduction of the ASP (P = 0.4574). The introduction of the ASP was associated with a significant impact on reducing the levels of CRAb (P = 0.0237). CONCLUSIONS: The introduced antimicrobial stewardship interventions contributed to a reduction in the use of several broad-spectrum antibiotics, reversed the trends of increasing use of other antibiotics and were associated with a significant reduction in CRAb.
Authors: Zuhdi O Elifranji; Bassem Haddad; Anas Salameh; Shehadeh Alzubaidi; Noor Yousef; Mohammad Al Nawaiseh; Ahmad Alkhatib; Razan Aburumman; Abdulrahman M Karam; Muayad I Azzam; Mohammad A Alshrouf Journal: Adv Orthop Date: 2022-07-04
Authors: Zainab Said Al-Hashimy; Barbara R Conway; Mubarak Al-Yaqoobi; Faryal Khamis; Ghalib Zahran Al Mawali; Aisha Mahad Al Maashani; Yaqoob Said Al Hadhrami; Said Salim Al Alawi; Mohammed Said Al Mamari; William J Lattyak; Elizabeth A Lattyak; Motasem Aldiab; Ian Gould; José-María López-Lozano; Mamoon A Aldeyab Journal: Antibiotics (Basel) Date: 2022-06-07
Authors: Ghaith M Al-Taani; Sayer Al-Azzam; Reema A Karasneh; Adel Shaban Sadeq; Nadia Al Mazrouei; Stuart E Bond; Barbara R Conway; Mamoon A Aldeyab Journal: Antibiotics (Basel) Date: 2022-01-28
Authors: Mariateresa Ceparano; Valentina Baccolini; Giuseppe Migliara; Claudia Isonne; Erika Renzi; Daniela Tufi; Corrado De Vito; Maria De Giusti; Maria Trancassini; Francesco Alessandri; Giancarlo Ceccarelli; Francesco Pugliese; Paolo Villari; Maria Angiulli; Stefania Battellito; Arianna Bellini; Andrea Bongiovanni; Lucilla Caivano; Marta Castellani; Monica Coletti; Alessia Cottarelli; Ludovica D'Agostino; Andrea De Giorgi; Chiara De Marchi; Irma Germani; Dara Giannini; Elisa Mazzeo; Shadi Orlandi; Matteo Piattoli; Eleonora Ricci; Leonardo Maria Siena; Alessandro Territo; Gianluca Vrenna; Stefano Zanni; Carolina Marzuillo Journal: Microorganisms Date: 2022-03-28
Authors: Mamoon A Aldeyab; Stuart E Bond; Barbara R Conway; Jade Lee-Milner; Jayanta B Sarma; William J Lattyak Journal: Antibiotics (Basel) Date: 2022-08-17